Dr. Spetzler talks about about how machine learning is transforming massive datasets into predictive biomarkers that help clinicians personalize cancer treatment — faster, smarter, and with greater precision.
We also explore:
- Why AI for drug discovery is gaining massive traction across oncology research
- Caris’ 37 poster presentations at ASCO 2025, including a standout in early-stage breast cancer research using AI-powered imaging to predict recurrence up to 18 years in advance
- The growing role of public-private partnerships in propelling cancer innovation forward
- How large-scale data + AI = hope for more targeted, proactive patient care
Dr. Spetzler's bold vision is rooted in the idea that AI isn’t just about efficiency — it’s about empathy and getting ahead of disease before it can take hold.
☕ Grab your favorite cup of tea and tune in for this inspiring episode of #HITeaWithGrace — where science meets soul in the fight against cancer.
👉 Don’t forget to like, comment, and subscribe for more real talk on the future of health tech.
#ASCO2025 #HITeaWithGrace #AIinOncology #HealthIT #CancerResearch #Biomarkers #DrugDiscovery #PrecisionMedicine #WomenInHealthIT #PatientCenteredCare #CarisLifeSciences #HealthcareAI